相关实验视频
Updated: Jul 1, 2025

07:17
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
10.6K
化疗在不同组织类型的胰腺癌中的比较有效性:基于PSM的研究,使用SEER数据库
Canhua Luo1, Linfeng Fan2, Weijian Lun1
1Department of Gastroenterology, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, China.
Journal of chemotherapy (Florence, Italy)
|March 14, 2024
概括
化疗改善了大多数胰腺癌类型的存活率,特别是晚期胰腺管道腺癌. 然而,它的有效性因组织学而异,胰腺粘膜腺癌没有显著的益处.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 流行病学 流行病学
背景情况:
- 胰腺癌包括多种不同的组织学亚型,预后不同.
- 化疗对这些亚型的生存的影响尚未完全阐明.
研究的目的:
- 为了比较化疗在不同胰腺癌组织类型的疗效.
- 根据治疗和组织学分析总生存率 (OS) 和癌症特异性生存率 (CSS).
主要方法:
- 利用了监测,流行病学和最终结果 (SEER) 数据库 (2004-2015) 中的7653名患者的数据.
- 员工倾向性得分匹配 (PSM) 以减少偏差.
- 应用Kaplan-Meier生存曲线和日志等级测试进行生存分析.
主要成果:
- 在所有患者中,化疗显著改善了与没有化疗相比的OS和CSS (p < 0.001).
- 在PSM后的分析显示,化疗对胰腺管腺癌 (PDAC),胰腺状癌 (PASC) 和胰腺粘素生成腺癌 (PMPAC) 有好处 (p < 0.001).
- 胰腺粘膜腺癌 (PMAC) 与化疗没有显著的生存差异 (p = 0.2586). 比PASC和PMPAC,PDAC的生存率更高. PMPAC呈现出更多的转移和更差的生存率.
结论:
- 化疗对大多数胰腺癌组织类型,特别是晚期PDAC是一种有益的治疗方法.
- 组织学亚型显著影响化疗反应和患者生存结果.
- 尽管进行化疗,PMPAC的转移率高导致其预后较差.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
183
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
183
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345

